|
|
Volumn 348, Issue , 2014, Pages
|
|
Erratum: The missing data that cost $20bn (BMJ (Online) (2014) 348 (g2695) DOI: 10.1136/bmj.g2695);The missing data that cost $20bn
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
OSELTAMIVIR;
SIALIDASE INHIBITOR;
ZANAMIVIR;
ACCESS TO INFORMATION;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG CONTROL;
DRUG INDUSTRY;
DRUG MARKETING;
EDITORIAL;
HUMAN;
PATIENT SAFETY;
PRIORITY JOURNAL;
|
|
EID: 84898605410
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g2746 Document Type: Erratum |
|
Times cited : (17)
|
|
References (0)
|
